Insights

Innovative Technology Vir Biotechnology's focus on advanced platform technologies such as next-generation antibody and protease-releasable masking platforms highlights their commitment to rapid development of targeted therapies, presenting opportunities to offer complementary biotech tools, manufacturing services, or platform licensing solutions.

Pipeline Expansion With recent initiation of pivotal trials for chronic hepatitis delta and ongoing development in oncology, Vir Biotechnology is actively expanding its therapeutic pipeline, signaling potential demand for clinical research services, diagnostic collaborations, and regulatory consulting support.

Strategic Partnerships Partnerships like the licensing agreement with Amunix indicate an openness to external collaborations, offering avenues for joint ventures, licensing, or co-development agreements with organizations seeking to leverage innovative biotech assets.

Financial Growth Focus Although currently with moderate revenues around 50 to 100 million dollars, Vir's recent hiring and restructuring efforts show a focus on strategic investments and scaling, which could benefit suppliers of clinical infrastructure, lab equipment, or pharmaceutical manufacturing solutions.

Market Engagement Participation in industry events and active communication of progress suggest Vir Biotechnology is positioned to expand its network within the healthcare and biotech sectors, creating opportunities for business development teams to connect through conferences, collaborations, or vendor relationships.

Vir Biotechnology, Inc. Tech Stack

Vir Biotechnology, Inc. uses 8 technology products and services including CUDA, Tableau, Microsoft Azure, and more. Explore Vir Biotechnology, Inc.'s tech stack below.

  • CUDA
    Audio, Video, Graphics
  • Tableau
    Business Intelligence
  • Microsoft Azure
    Platform As A Service
  • Boardvantage
    Project Management
  • reCAPTCHA
    Security
  • GraphPad Prism
    Visualisation Software
  • Adobe Creative Suite
    Visualisation Software
  • Google Analytics
    Web Analytics

Media & News

Vir Biotechnology, Inc.'s Email Address Formats

Vir Biotechnology, Inc. uses at least 1 format(s):
Vir Biotechnology, Inc. Email FormatsExamplePercentage
FLast@vir.bioJDoe@vir.bio
86%
First.Last@vir.bioJohn.Doe@vir.bio
7%
FL@vir.bioJD@vir.bio
5%
FirstLast@vir.bioJohnDoe@vir.bio
2%

Frequently Asked Questions

Where is Vir Biotechnology, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc.'s main headquarters is located at 1800 Owens St, Suite 900 San Francisco, California 94158, US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Vir Biotechnology, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Vir Biotechnology, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vir Biotechnology, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc. is a publicly traded company; the company's stock symbol is VIR.

What is Vir Biotechnology, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc.'s official website is vir.bio and has social profiles on LinkedInCrunchbase.

What is Vir Biotechnology, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vir Biotechnology, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, Vir Biotechnology, Inc. has approximately 501 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. T.Chief Operating Officer: J. F.Vice President Of Business Development (ended 01/24): L. R.. Explore Vir Biotechnology, Inc.'s employee directory with LeadIQ.

What industry does Vir Biotechnology, Inc. belong to?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc. operates in the Biotechnology Research industry.

What technology does Vir Biotechnology, Inc. use?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc.'s tech stack includes CUDATableauMicrosoft AzureBoardvantagereCAPTCHAGraphPad PrismAdobe Creative SuiteGoogle Analytics.

What is Vir Biotechnology, Inc.'s email format?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc.'s email format typically follows the pattern of FLast@vir.bio. Find more Vir Biotechnology, Inc. email formats with LeadIQ.

How much funding has Vir Biotechnology, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2025, Vir Biotechnology, Inc. has raised $50M in funding. The last funding round occurred on Oct 03, 2023 for $50M.

When was Vir Biotechnology, Inc. founded?

Minus sign iconPlus sign icon
Vir Biotechnology, Inc. was founded in 2016.

Vir Biotechnology, Inc.

Biotechnology ResearchUnited States501-1000 Employees

At Vir Biotechnology, Inc., we leverage the immense potential of the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer.

We focus on the therapeutic areas in which we believe we can most benefit patients. Our foundational efforts in chronic hepatitis delta are complemented by strategic programs in oncology. Every day, we work with the utmost urgency to deliver potentially transformative medicines for patients.

Our pipeline is built on two technology platforms which enable us to rapidly identify, optimize and advance candidates from concepts to the clinic: our next-generation antibody platform and our protease-releasable masking platform in infectious disease and cancer. Explore our full pipeline here: https://bit.ly/3tr7FPm

It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir Bio's recruiting process: https://bit.ly/461EgJN

Section iconCompany Overview

Headquarters
1800 Owens St, Suite 900 San Francisco, California 94158, US
Phone number
Website
vir.bio
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
VIR
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
501-1000

Section iconFunding & Financials

  • $50M

    Vir Biotechnology, Inc. has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Oct 03, 2023 in the amount of $50M.

  • $50M$100M

    Vir Biotechnology, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M

    Vir Biotechnology, Inc. has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Oct 03, 2023 in the amount of $50M.

  • $50M$100M

    Vir Biotechnology, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.